Integra LifeSciences Holdings Corporation (IART) vs PROCEPT BioRobotics Corporation (PRCT)

Integra LifeSciences Holdings Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. Integra LifeSciences Holdings Corporation and PROCEPT BioRobotics Corporation are of similar size ($1.1B and $1.0B). PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 1.60%. Integra LifeSciences Holdings Corporation has the higher net margin (−0.44% vs −32.5%) and the higher return on invested capital (1.58% vs −43.6%). Across the 18 metrics below, Integra LifeSciences Holdings Corporation leads on 12 and PROCEPT BioRobotics Corporation on 6.

Valuation

Metric IART PRCT Medical Devices median
P/E n/m n/m 23.22
P/S 0.62 2.97 2.34
P/B 0.98 2.95 2.33
Price to free cash flow 39.57 n/m 23.72
EV/EBITDA 11.92 n/m 11.54
EV/Sales 1.62 2.46 2.24
Earnings yield (0.68%) (11.04%) (10.09%)
Free cash flow yield 2.53% (8.47%) (8.47%)

Profitability

Metric IART PRCT Medical Devices median
Gross margin 52.47% 64.22% 56.01%
Operating margin 3.98% (33.86%) (15.03%)
Net margin (0.44%) (32.54%) (20.40%)
Free cash flow margin 1.57% (25.17%) (7.24%)
Return on equity (0.70%) (30.24%) (15.32%)
Return on assets (0.20%) (22.12%) (19.72%)
Return on invested capital 1.58% (43.57%) (10.33%)

Growth

Metric IART PRCT Medical Devices median
Revenue growth (TTM) 1.60% 22.69% 8.80%
EPS growth (last fiscal year) (7,388.89%) 1.71% 29.03%
Revenue growth, 5-year CAGR 3.57% 109.04% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IART PRCT Medical Devices median
Debt to equity 1.75 0.15 0.07
Current ratio 3.60 6.55 2.50
Net debt to EBITDA (4.62) 2.41 0.49

Dividend

Metric IART PRCT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric IART PRCT Medical Devices median
Market cap 1.05b 1.04b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack